Abcam

 

About Abcam

Abcam partners with life science organisations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise. By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products. With eleven sites globally, many of Abcam’s 1,100 strong team are co-located in the world's leading life science research hubs, complementing a global network of services and support. To discover more, please visit www.abcam.com and www.abcamplc.com.

Therapeutic Areas

Oncology

Technologies

Other

Company Type

Biotechnology – R&D services

State of Ownership

Private

Sponsorship Group

Networker